An Information Portal to 111749 Biological Macromolecular Structures

MIY is found in 11 entries
  •   Chemical Component Summary   Hide
    Identifiers (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
    Synonyms MINOCYCLINE
    Formula C23 H27 N3 O7
    Molecular Weight 457.48 g/mol
    Type non-polymer
    Isomeric SMILES
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01017   (Stereoisomeric match)
    Name Minocycline
    • approved
    • investigational
    Description A tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections. [PubChem]
    • (4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
    • 7-Dimethylamino-6-demethyl-6-deoxytetracycline
    • Minociclina
    • Minociclinum
    • Minocyclin
    • Minocyclinum
    Salts Minocycline Hydrochloride
    Brand names
    • Arestin
    • Dynacin
    • Minocin
    • Minocycline
    • Minocycline Hydrochloride
    • Solodyn
    • Ximino
    Affected organism Enteric bacteria and other eubacteria
    Indication For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by Streptococcus pneumoniae and for the treatment of asymptomatic carriers of Neisseria meningitidis.
    Pharmacology Minocycline, the most lipid soluble and most active tetracycline antibiotic, is, like doxycycline, a long-acting tetracycline. Minocycline's effects are related to the inhibition of protein synthesis. Although minocycline's broader spectrum of activity, compared to other members of the group, includes activity against Neisseria meningitidis, its use as a prophylaxis is no longer recomended because of side effects (dizziness and vertigo). Current research is examining the possible neuroprotective effects of minocycline against progression of Huntington's Disease, an inherited neurodegenerative disorder. The neuroprotective action of minocycline may include its inhibitory effect on 5-lipoxygenase, an inflammatory enzyme associated with brain aging.
    Mechanism of action Minocycline passes directly through the lipid bilayer or passively diffuses through porin channels in the bacterial membrane. Tetracyclines like minocycline bind to the 30S ribosomal subunit, preventing the binding of tRNA to the mRNA-ribosome complex and interfering with protein synthesis.
    Route of administration
    • intravenous
    • oral
    • Anti-Bacterial Agents
    • Tetracyclines
    • A01AB23
    • J01AA08
    AHFS-Code 08:12.24
    CAS number 10118-90-8
    Name Sequence search Pharmacological action Actions
    30S ribosomal protein S4   Search  yes inhibitor
    Matrix metalloproteinase-9   Search  unknown inhibitor
    30S ribosomal protein S9   Search  yes inhibitor
    Vascular endothelial growth factor A   Search  unknown inhibitor
    Arachidonate 5-lipoxygenase   Search  unknown inhibitor
Ligand Image